SphingoTec announces first data on the kidney function biomarker penKid as a promising tool in supporting early initiation and liberation from RRT. Although RRT remains a pivotal measure in treating…
Privacy Policy
1. An overview of data protection
General information
The following information will provide you with an easy to navigate overview of what will happen with your personal data when…
Boditech Med Inc. and SphingoTec GmbH have entered into a non-exclusive royalty-bearing license agreement. Under the terms of this agreement, Boditech has obtained the rights to develop and…
Nexus IB10 Biomarker Portfolio
Innovative biomarker tests
Standard of care biomarker tests
Disclaimer
Sphingotest® penKid®, sphingotest® bio-ADM®, sphingotest® DPP3 are offered for in vitro…
Follow our Journey on Social Media
View all Events
View all News
Events & Expos
Latest News
Subscribe to our Newsletter
Follow the link below to subscribe to our…
With the mission of improving patient management in critical care settings, SphingoTec has started a series of collaboration with internationally leading academic and non-academic medical centers.
In severely ill COVID-19 patients, besides the main complications that include respiratory, cardiovascular and kidney diseases, an emerging body of evidence shows that endothelial function plays a…